logo-loader
AIM:INS

Instem PLC

Receive alerts
Market:
AIM
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Instem PLC is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for study management, regulatory submissions, clinical trial acceleration, and informatics-based insight generation.

The company's solutions are in use by over 700 customers worldwide, including all of the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster.

Snapshot

  • Instem gets five approaches after agreeing Archimed deal
  • Instem targeting new tech-led approach in drug discovery
  • Instem's acquisition of The Edge highly complementary, says broker
  • Instem proves in step with groundbreaking market needs as it posts strong 2022 performance

Insight Widest with the analysis, Proactive gives perspectives that others don't.